-+ 0.00%
-+ 0.00%
-+ 0.00%
AdvanSix (ASIX) Back To Back EPS Losses Test Profitability Stability Narrative
Share
Listen to the news

AdvanSix FY 2025 Earnings Snapshot

AdvanSix (ASIX) has wrapped up FY 2025 with Q4 revenue of about US$359.9 million and a basic EPS loss of roughly US$0.10, alongside trailing twelve month EPS of about US$1.83. Over recent periods the company has seen quarterly revenue move from US$329.1 million in Q4 2024 to US$377.8 million in Q1 2025, US$410.0 million in Q2 2025, US$374.5 million in Q3 2025 and US$359.9 million in Q4 2025. Quarterly basic EPS ranged from a small profit of roughly US$0.01 in Q4 2024 to a loss of about US$0.10 in Q4 2025 after stronger readings earlier in the year. With trailing net profit margins sitting at 3.2%, these results set up a conversation about how durable that profitability is and what it might signal for future earnings power.

See our full analysis for AdvanSix.

With the numbers on the table, the next step is to see how this earnings profile lines up against the prevailing narratives around AdvanSix, and where the data either backs those views or calls them into question.

See what the community is saying about AdvanSix

NYSE:ASIX Revenue & Expenses Breakdown as at Feb 2026
NYSE:ASIX Revenue & Expenses Breakdown as at Feb 2026

Profit Margins Hold, But Quarterly Swings Are Sharp

  • Over the last 12 months, AdvanSix earned net income of US$49.3 million on about US$1.5b of revenue, giving a 3.2% net margin compared with 2.9% in the prior year, while quarterly results ranged from a loss of US$2.8 million in Q4 2025 to a profit of US$31.4 million in Q2 2025.
  • Analysts' consensus view points to capacity expansion and operational programs as supports for through cycle profitability, yet the recent quarterly losses test how smooth that story really is.
    • The consensus narrative highlights ammonium sulfate capacity growth and programs like SUSTAIN as efforts to improve earnings stability, but the back to back Q3 and Q4 2025 losses of roughly US$2.6 million and US$2.8 million show that short term profit can still be quite uneven.
    • At the same time, trailing EPS of about US$1.83 and a 3.2% margin sit alongside that 11.6% earnings growth over the last year. This supports the idea that full year profitability can still hold up even when some quarters are weak.

Investors who want to see how this profit profile fits into the broader story around crops, fertilizer demand and specialty chemicals might find it useful to see what the community is debating right now about AdvanSix: 🐂 AdvanSix Bull Case

Five Year Earnings Pressure Versus Recent 11.6% Lift

  • Over the past five years, earnings declined at an annualized rate of 19.1%, yet over the last 12 months earnings grew 11.6% versus the prior year, with trailing EPS at about US$1.83.
  • Bears focus on that 19.1% annualized decline as a sign of prolonged pressure, and the latest Q3 and Q4 2025 losses give them more to point to.
    • Critics highlight that two of the last four quarters, Q3 and Q4 2025, show basic EPS losses of roughly US$0.10 per share even though the trailing period still shows a profit. They see this as evidence that the longer term downtrend has not fully reversed.
    • The same bears also point to the dividend yield of 3.41% not being well covered by free cash flow, arguing that if earnings wobble again the company may have less flexibility in how it uses cash.

If you are weighing these mixed earnings trends against the cautious view, it can help to see the full bear case laid out in one place: 🐻 AdvanSix Bear Case

Low 10.2x P/E Against DCF Fair Value

  • The shares trade on a P/E of 10.2x at a price of US$18.77, below both the US Chemicals industry average of 28.6x and peer average of 28.9x, and well under a DCF fair value of about US$99.12.
  • Consensus narrative sees catalysts like carbon capture tax credits and insurance settlements as supports for cash flow. This lines up with the idea that the current valuation may not fully reflect those benefits.
    • The DCF fair value of roughly US$99.12 compared with the US$18.77 share price indicates the stock is trading very far under that model based estimate, which value focused investors may compare against the 3.2% net margin and recent 11.6% earnings growth.
    • Analysts also flag carbon capture tax credits lowering the effective tax rate and final insurance settlements adding cash, and investors can set those one off supports against the five year 19.1% annualized earnings decline when thinking about how much weight to give the low P/E.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for AdvanSix on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Mixed signals across earnings, margins and valuation can feel messy, so do not wait to examine the full picture yourself and weigh up the company's 2 key rewards and 2 important warning signs.

See What Else Is Out There

AdvanSix's recent quarterly losses, uneven earnings over the last year, and a dividend not well covered by free cash flow may leave you questioning its resilience.

If those profit swings and cash coverage concerns make you cautious, shift your focus toward companies filtered for steadier fundamentals with 87 resilient stocks with low risk scores and see how they compare right now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending